UroGen Pharma Ltd.

www.urogen.com

Formerly TheraCoat

High-Tech Company
Public Company

(NASDAQ GS: URGN)

Graduated from: Granot Ventures

TECH VERTICALS

Biotechnology, MedTech, Pharmaceuticals, Therapeutics

General Data

Sector

Biomed

TECHNOLOGY

RTGel® - an innovative hydrogel that possesses dynamic, reverse-thermal properties — exists as a liquid at lower temperatures and converts to gel form at body temperature. RTGel® is designed to be formulated with an active drug and instille...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

PIPE

Jul. 27, 2023

Revenue Growth

$120m

$530m

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated:	May 20, 2025
IVC Number:	A1000000003340